Mateon Therapeutics Inc Common Stock
Why Robinhood?
You can watch MATN and buy or sell other stocks, ETFs, and their options commission-free!About MATN
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
MATN Key Statistics
Stock Snapshot
The current Mateon Therapeutics Inc Common Stock(MATN) stock price is $0.26, with a market capitalization of 114.26M. The stock trades at a price-to-earnings (P/E) ratio of -7.96.
During the trading day, Mateon Therapeutics Inc Common Stock(MATN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 317.65K.
Over the past 52 weeks, Mateon Therapeutics Inc Common Stock(MATN) stock has traded between a high of $0.11 and a low of $0.02.
Over the past 52 weeks, Mateon Therapeutics Inc Common Stock(MATN) stock has traded between a high of $0.11 and a low of $0.02.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.